Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver

Toxicology Mechanisms and Methods

Volumn 26, Issue 1, 2016, Pages 46-53

  Reza, Hasan Mahmud ^a   Tabassum, Nabila ^a   Sagor, Md Abu Taher ^a   Chowdhury, Mohammed Riaz Hasan ^a   Rahman, Mahbubur ^a   Jain, Preeti ^a   Alam, Md Ashraful ^a  

^a SOUTHERN UNIVERSITY BANGLADESH   (Bangladesh)

Author keywords

Angiotensin converting enzyme; fibrosis; inflammation; oxidative stress; ramipril

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CATALASE; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; RAMIPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS; HISTOPATHOLOGY; INFLAMMATORY CELL; LIPID PEROXIDATION; LIVER FUNCTION; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; CARBON TETRACHLORIDE POISONING; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION; LIVER CIRRHOSIS; LONG EVANS RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARBON TETRACHLORIDE POISONING; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; INFLAMMATION; LIVER CIRRHOSIS; OXIDATIVE STRESS; RAMIPRIL; RATS; RATS, LONG-EVANS;

EID: 84958537737     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2015.1124956     Document Type: Article

References (60)

1. Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT. (2011). The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci 56: 564-8
2. 4-induced liver injury in rats. Sci Pharm 78: 881-96
3. Bataller R, Gabele E, Parsons CJ, et al. (2005). Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. J Hepatol 41: 1046-55
4. Bataller R, Schwabe RF, Choi YH, et al. (2003a). NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-94
5. Bataller RN, Gãbele E, Schoonhoven R, et al. (2003b). Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 285: G642-51
6. Bieghs V, Trautwein C. (2013). The innate immune response during liver inflammation and metabolic disease. Trends Immunol 34: 446-52
7. Bradley PP, Priebat DA, Christensen RD, Rothstein G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-9
8. Britton RS, Bacon BR. (1994). Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 41: 343-8
9. Chance B, Maehly A. (1955). Assay of catalase and peroxidases. Methods Enzymol 11: 764-75
10. Colmenero J, Bataller R, Sancho-Bru P, et al. (2009). Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am J Physiol Gastrointest Liver Physiol 297: G726-34
11. Cui X, Shimizu I, Lu G, et al. (2003). Inhibitory effect of a soluble transforming growth factor-α type II receptor on the activation of rat hepatic stellate cells in primary culture. J Hepatol 39: 731-7
12. Douros A, Kauffmann W, Bronder E, et al. (2013). Ramipril-induced liver injury: case report and review of the literature. Am J Hypertens 26: 1070-5
13. Du WD, Zhang YE, Zhai WR, Zhou XM. (1999). Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 5: 397-403
14. Ekor M, Odewabi AO, Kale OE, et al. (2011). Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats. Hum Exp Toxicol 30: 1840-8
15. El-Khatib AS, Mansour MA. (2001). Prior treatment with captopril attenuates carbon tetrachloride-induced liver injury in mice. Res Commun Mol Pathol Pharmacol 110: 3-16
16. Galli A, Svegliati-Baroni G, Ceni E, et al. (2005). Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. J Hepatol 41: 1074-84
17. Ghiassi-Nejad Z, Friedman SL. (2008). Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol 2: 803-16
18. Giannini EG, Testa R, Savarino V. (2005). Liver enzyme alteration: a guide for clinicians. CMAJ 172: 367-79
19. Guillaud O, Gurram KC, Puglia M, et al. (2013). Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis c after liver transplantation. Transplant Proc 45: 2331-6
20. Hagley M, Hulisz D, Burns C. (1993). Hepatotoxicity associated with angiotensin-converting enzyme inhibitors. Ann Pharmacother 27: 228-31
21. He SX, Luo JY, Wang YP, et al. (2006). Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats. World J Gastroenterol 12: 3924-8
22. Hernandez-Gea V, Friedman SL. (2011). Pathogenesis of liver fibrosis. Annu Rev Pathol Mech 6: 425-56
23. Hirose A, Ono M, Saibara T, et al. (2007). Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 45: 1375-81
24. Ishizaka N, Saito K, Noiri E, et al. (2005). Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver. Am J Physiol Regul Integr Comp Physiol 288: R1063-70
25. Izzo JJL, Weir MR. (2011). Angiotensin-converting enzyme inhibitors. J Clin Hypertens (Greenwich) 13: 667-75
26. Jin CF, Li B, Lin SM, et al. (2013). Mechanism of the inhibitory effects of Eucommia ulmoides Oliv. cortex extracts (EUCE) in the CCl 4-induced acute liver lipid accumulation in rats. Int J Endocrinol 2013: 751-854
27. Jollow D, Mitchell J, Zampaglione N, Gillette J. (1974). Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11: 151-69
28. Jonsson JR, Clouston AD, Ando Y, et al. (2001). Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 121: 148-55
29. Khan R. (2012). Protective effects of Sonchus asper (L.) Hill, (Asteraceae) against CCl(4-)induced oxidative stress in the thyroid tissue of rats. BMC Complement Altern Med 12: 181
30. Kim M, Baik S, Park D, et al. (2008). Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastroenterol 43: 889-96
31. Makani H, Messerli FH, Romero J, et al. (2012). Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110: 383-91
32. Metwally MA, Zein CO, Zein NN. (2004). Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 99: 286-91
33. Mohammed NA, Abd El-Aleem S, Appleton I, et al. (2003). Expression of nitric oxide synthase isoforms in human liver cirrhosis. J Pathol 200: 647-55
34. Nabeshima Y, Tazuma S, Kanno K, et al. (2006). Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis. Biochem Biophys Res Commun 346: 658-64
35. Nelson JE, Wilson L, Brunt EM, et al. (2010). Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 53: 448-57
36. Niehaus WG, Samuelsson B. (1968). Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6: 126-30
37. Otogawa K, Kinoshita K, Fujii H, et al. (2007). Erythrophagocytosis by liver macrophages (kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis. Am J Pathol 170: 967-80
38. Paizis G, Cooper ME, Schembri JM, et al. (2002). Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-76
39. Paizis G, Tikellis C, Cooper ME, et al. (2005). Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54: 1790-6
40. Purohit V, Russo D, Salin M. (2003). Role of iron in alcoholic liver disease: introduction and summary of the symposium. Alcohol 30: 93-7
41. Ramaiah SK, Jaeschke H. (2007). Role of Neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 35: 757-66
42. 4-induced liver fibrosis in Hjv-/-mice, associated with an oxidative burst and precocious profibrogenic gene expression. PLoS One 6: e25138
43. Tilg H, Moschen AR. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52: 1836-46
44. Tipoe G, Leung T, Liong E, et al. (2006). Inhibitors of inducible nitric oxide (NO) synthase are more effective than an no donor in reducing carbon tetrachloride-induced acute liver injury. Histol Histopathol 21: 1157-65
45. Tiwari BK, Kumar D, Abidi AB, Rizvi SI. (2014). Efficacy of Composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats. ISRN Pharmacol 2014: 7
46. Tomita K, Tamiya G, Ando S, et al. (2006). Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55: 415-24
47. Tracey WR, Tse J, Carter G. (1995). Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 272: 1011-15
48. Tung BY, Emond MJ, Bronner MP, et al. (2003). Hepatitis C, iron status, and disease severity: relationship with HFE mutations. J Gastroenterol 124: 318-26
49. Turkay C, Yonem O, Arici S, et al. (2008). Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis. Dig Dis Sci 53: 789-93
50. Ueki M, Koda M, Yamamoto S, et al. (2006). Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. J Gastroenterol 41: 996-1004
51. von Montfort C, Matias N, Fernandez A, et al. (2012). Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J Hepatol 57: 852-9
52. Wang HJ, Gao B, Zakhari S, Nagy LE. (2012). Inflammation in Alcoholic Liver Disease. Annu Rev Nutr 32: 343-68
53. Weber LWD, Boll M, Stampfl A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33: 105-36
54. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-13
55. Wu CH. (1999). Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis. World J Gastroenterol 5: 388-90
56. Yang L, Bataller R, Dulyx J, et al. (2005). Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 43: 317-23
57. Yang Q, Shi Y, He J, Chen Z. (2012). The evolving story of macrophages in acute liver failure. Immunol Lett 147: 1-9
58. Yeung E, Wong FS, Wanless IR, et al. (2003). Ramipril-associated hepatotoxicity. Arch Pathol Lab Med 127: 1493-7
59. Yi E-T, Liu R-X, Wen Y, Yin C-H. (2012). Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats. Acta Pharmacol Sin 33: 1518-24
60. 4-induced acute liver injury of mice. Free Radic Biol Med 29: 870-80